300 related articles for article (PubMed ID: 21691195)
1. Phosphorylation of GSK-3β mediates intralipid-induced cardioprotection against ischemia/reperfusion injury.
Rahman S; Li J; Bopassa JC; Umar S; Iorga A; Partownavid P; Eghbali M
Anesthesiology; 2011 Aug; 115(2):242-53. PubMed ID: 21691195
[TBL] [Abstract][Full Text] [Related]
2. Intralipid, a clinically safe compound, protects the heart against ischemia-reperfusion injury more efficiently than cyclosporine-A.
Li J; Iorga A; Sharma S; Youn JY; Partow-Navid R; Umar S; Cai H; Rahman S; Eghbali M
Anesthesiology; 2012 Oct; 117(4):836-46. PubMed ID: 22814384
[TBL] [Abstract][Full Text] [Related]
3. Ventricular hypertrophy abrogates intralipid-induced cardioprotection by alteration of reperfusion injury salvage kinase/glycogen synthase kinase 3β signal.
Ma LL; Ge HW; Kong FJ; Qian LB; Hu BC; Li Q; Xu L; Liu JQ; Xu YX; Sun RH
Shock; 2014 May; 41(5):435-42. PubMed ID: 24430545
[TBL] [Abstract][Full Text] [Related]
4. Intralipid protects the heart in late pregnancy against ischemia/reperfusion injury via Caveolin2/STAT3/GSK-3β pathway.
Li J; Ruffenach G; Kararigas G; Cunningham CM; Motayagheni N; Barakai N; Umar S; Regitz-Zagrosek V; Eghbali M
J Mol Cell Cardiol; 2017 Jan; 102():108-116. PubMed ID: 27847332
[TBL] [Abstract][Full Text] [Related]
5. Morphine preconditioning confers cardioprotection in doxorubicin-induced failing rat hearts via ERK/GSK-3β pathway independent of PI3K/Akt.
He SF; Jin SY; Wu H; Wang B; Wu YX; Zhang SJ; Irwin MG; Wong TM; Zhang Y
Toxicol Appl Pharmacol; 2015 Nov; 288(3):349-58. PubMed ID: 26296503
[TBL] [Abstract][Full Text] [Related]
6. Remifentanil Preconditioning Reduces Postischemic Myocardial Infarction and Improves Left Ventricular Performance via Activation of the Janus Activated Kinase-2/Signal Transducers and Activators of Transcription-3 Signal Pathway and Subsequent Inhibition of Glycogen Synthase Kinase-3β in Rats.
Qiao S; Mao X; Wang Y; Lei S; Liu Y; Wang T; Wong GT; Cheung CW; Xia Z; Irwin MG
Crit Care Med; 2016 Mar; 44(3):e131-45. PubMed ID: 26468894
[TBL] [Abstract][Full Text] [Related]
7. Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3beta.
Feng J; Lucchinetti E; Ahuja P; Pasch T; Perriard JC; Zaugg M
Anesthesiology; 2005 Nov; 103(5):987-95. PubMed ID: 16249673
[TBL] [Abstract][Full Text] [Related]
8. Rosuvastatin protects isolated hearts against ischemia-reperfusion injury: role of Akt-GSK-3β, metabolic environment, and mitochondrial permeability transition pore.
Vélez DE; Mestre-Cordero VE; Hermann R; Perego J; Harriet S; Fernandez-Pazos MLM; Mourglia J; Marina-Prendes MG
J Physiol Biochem; 2020 Feb; 76(1):85-98. PubMed ID: 31916218
[TBL] [Abstract][Full Text] [Related]
9. Myocardial reperfusion injury management: erythropoietin compared with postconditioning.
Tamareille S; Ghaboura N; Treguer F; Khachman D; Croué A; Henrion D; Furber A; Prunier F
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2035-43. PubMed ID: 19617412
[TBL] [Abstract][Full Text] [Related]
10. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore.
Liu CW; Yang F; Cheng SZ; Liu Y; Wan LH; Cong HL
Cardiovasc Ther; 2017 Feb; 35(1):3-9. PubMed ID: 27580017
[TBL] [Abstract][Full Text] [Related]
11. G Protein-Coupled Estrogen Receptor 1 Mediates Acute Estrogen-Induced Cardioprotection via MEK/ERK/GSK-3β Pathway after Ischemia/Reperfusion.
Kabir ME; Singh H; Lu R; Olde B; Leeb-Lundberg LM; Bopassa JC
PLoS One; 2015; 10(9):e0135988. PubMed ID: 26356837
[TBL] [Abstract][Full Text] [Related]
12. Sufentanil postconditioning protects the myocardium from ischemia-reperfusion via PI3K/Akt-GSK-3β pathway.
Wu QL; Shen T; Ma H; Wang JK
J Surg Res; 2012 Dec; 178(2):563-70. PubMed ID: 22727941
[TBL] [Abstract][Full Text] [Related]
13. Sevoflurane confers additive cardioprotection to ethanol preconditioning associated with enhanced phosphorylation of glycogen synthase kinase-3β and inhibition of mitochondrial permeability transition pore opening.
Onishi A; Miyamae M; Inoue H; Kaneda K; Okusa C; Inamura Y; Shiomi M; Koshinuma S; Momota Y; Figueredo VM
J Cardiothorac Vasc Anesth; 2013 Oct; 27(5):916-24. PubMed ID: 23266287
[TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.
Ghaboura N; Tamareille S; Ducluzeau PH; Grimaud L; Loufrani L; Croué A; Tourmen Y; Henrion D; Furber A; Prunier F
Basic Res Cardiol; 2011 Jan; 106(1):147-62. PubMed ID: 20981553
[TBL] [Abstract][Full Text] [Related]
15. From local to global: lipid emulsion (intralipid) makes a move.
Kawaraguchi Y; Roth DM; Patel HH
Anesthesiology; 2011 Aug; 115(2):226-8. PubMed ID: 21654493
[No Abstract] [Full Text] [Related]
16. Sphingosine 1-Phosphate Postconditioning Protects Against Myocardial Ischemia/reperfusion Injury in Rats via Mitochondrial Signaling and Akt-Gsk3β Phosphorylation.
Fang R; Zhang LL; Zhang LZ; Li W; Li M; Wen K
Arch Med Res; 2017 Feb; 48(2):147-155. PubMed ID: 28625317
[TBL] [Abstract][Full Text] [Related]
17. Curcumin protects against regional myocardial ischemia/reperfusion injury through activation of RISK/GSK-3β and inhibition of p38 MAPK and JNK.
Jeong CW; Yoo KY; Lee SH; Jeong HJ; Lee CS; Kim SJ
J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):387-94. PubMed ID: 22396328
[TBL] [Abstract][Full Text] [Related]
18. Bradykinin prevents reperfusion injury by targeting mitochondrial permeability transition pore through glycogen synthase kinase 3beta.
Park SS; Zhao H; Mueller RA; Xu Z
J Mol Cell Cardiol; 2006 May; 40(5):708-16. PubMed ID: 16516918
[TBL] [Abstract][Full Text] [Related]
19. Ischaemic post-conditioning protects both adult and aged Sprague-Dawley rat heart from ischaemia-reperfusion injury through the phosphatidylinositol 3-kinase-AKT and glycogen synthase kinase-3beta pathways.
Yin Z; Gao H; Wang H; Li L; Di C; Luan R; Tao L
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):756-63. PubMed ID: 19207715
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological postconditioning against myocardial infarction with a slow-releasing hydrogen sulfide donor, GYY4137.
Karwi QG; Whiteman M; Wood ME; Torregrossa R; Baxter GF
Pharmacol Res; 2016 Sep; 111():442-451. PubMed ID: 27378570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
